Menu
Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,266 | Dovepress* | 9,610+ | 958 | 10,568 | |
| PubMed Central* | 4,656 | 269 | 4,925 | ||
| Totals | 14,266 | 1,227 | 15,493 | ||
| *Since 11 April 2018 | |||||
View citations on PubMed Central and Google Scholar